热门资讯> 正文

iBio报告第三季度业绩

2024-05-14 05:12

iBio(IBIO) 0
Informatica Inc.(NYSE) 0

iBio press release (NYSE:IBIO): Q3 Cash, cash equivalents and restricted cash as of March 31, 2024 was approximately $6.4 million, inclusive of $1.1 million of restricted cash.
No revenue was reported for the third quarter ended March 31, 2024.

More on iBio

iBio climbs after AI-led drug discovery deal
iBio announces $15 million private placement
Financial information for iBio

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。